Year-end review of 2024

 

The sun and the moon change and the light and shadow flow

in the blink of an eye

The 2024 progress bar has been loaded to 99%

A year full of stories is about to turn

looking back on this year

We use our courage to cut the waves

The enthusiasm of ambition and the high attitude of charge

Firmly follow the path of innovative development in biomedicine

Successfully opened a "new chapter" in the innovation journey

in 2024

It was a wonderful year

It was an unforgettable year

It's a growing year

It's also a year of harvest

Time binds the years into a book

Writing the dazzling past

Spring life, summer long harvest, autumn harvest, winter storage

Standing at the ferry of time and looking back

Scenes emerge warmly

"Report card" is a year-end ceremony that lights up time

Rewind memories through frame by frame

Track those unforgettable moments in 2024...

Let the past be traced

Say goodbye to this year in witnessing and being witnessed

Welcome the New Year with blooming dreams

 

The whole formation is waiting and ready to go

Accelerate the construction of iPSC technology independent innovation platform

The first Science and Technology Committee was established

The establishment of the first Science and Technology Committee was an important milestone. It brought together experts and professors from well-known academic institutions such as Tongji University and Shanghai University of Science and Technology to create a high-quality development "think tank" and bring valuable academic resources to the company. At the same time, it will guide the company to achieve major breakthroughs in the cutting-edge technology field of iPSC, laying a solid foundation for the company's long-term development and the construction of core competitiveness.

Yuanvore Medicine Stem Cell Engineering Technology Center was officially opened

The stem cell engineering technology center has a total area of approximately 1200 square meters, including biochemistry, physics and chemistry, PCR laboratories, pathogenic microorganisms laboratories, as well as primary cell rooms, cell laboratories, stem cell banks, etc. with a 10,000-level cleanliness standard, which can meet the needs of cell reprogramming, gene editing, cell engineering, drug quality control testing and other purposes.

Anchoring goals and activating endogenous motivation with cohesion

We are targeting the iPSC track, an area full of challenges and opportunities. With the rapid development of regenerative medicine, induced pluripotent stem cell (iPSC) technology has become an important branch of the field of biomedicine. It not only provides unlimited possibilities for the establishment of disease models, but also opens up new horizons for cell therapy and drug screening.

In our laboratory, advanced equipment and precision instruments are operating quietly. They are the cornerstone of realizing dreams. Here, every experiment embodies the wisdom and sweat of the team, and every data analysis heralds a new breakthrough. Our goal is not only to keep up with the trend, but to lead the trend and become a pioneer in iPSC technological innovation.

Strive for progress and build momentum

Inspection of Shanghai Financial Industry Federation and Inclusive Financial Consultants

Shanghai Financial Industry Federation, Shanghai Civil Construction Enterprise Development Promotion Center and many inclusive financial advisers from Industrial and Commercial Bank of China, Agricultural Bank of China, Bank of Communications, Bank of Shanghai, Minsheng Bank, China Merchants Bank, Zheshang Bank, and HSBC visited Yuanwu Medical University to provide face-to-face financial consulting services! While proposing "clever tricks", the participating consultants introduced corresponding credit service products on site based on the characteristics of their own financial institutions to accurately meet the business and development needs of enterprises.

So far, many banks such as Bank of Shanghai and Bank of Communications have granted credit to enterprises. With the support of financial power, we have more confidence to realize our dreams and create miracles.

36 independent intellectual property rights

5 invention patents authorized

2 PCT invention patent applications

So far, the company has applied for a total of 36 intellectual property rights and 11 invention patents, of which 5 have been authorized, 2 have applied for PCT;12 soft works have been authorized.

The acquisition of these independent intellectual property rights not only highlights the company's profound strength in the fields of independent research and development and scientific research and innovation, but also injects strong impetus into the company's future development. At the same time, it also reflects the company's emphasis on intellectual property protection, provides a solid legal guarantee for the company's continuous innovation and market competition, and helps the company maintain its advantages in the fierce market competition and achieve sustainable development.

Forge ahead·Breakthrough and Innovation 

Science and technology small and medium-sized enterprises are put into storage

Complete R&D proof-of-concept

Initiate preclinical animal testing

Breakthrough and innovation and lead the trend of the times with determination to forge ahead

As an innovative company that bravely stands at the forefront in the field of iPSC technology, we have successfully realized the warehousing of technology-based small and medium-sized enterprises and successfully completed the R&D concept verification. At this critical development stage, we have not only deepened the core competitiveness of iPSC technology, but also made substantial progress in pipeline construction, especially in the fields of treatment of Parkinson's disease and osteoarthritis, and have entered preclinical research. During the animal testing phase, CMC process development will be launched soon. As iPSC technology becomes increasingly mature and is widely promoted in clinical applications, we look forward to making more innovative leaps in the field of cell therapy and are committed to bringing new treatments to patients that are safer, more effective and more economical. options.

The east wind is gathering momentum and spring mountains are expected

1

Inspection of leaders of Pudong Association for Science and Technology

Gu Bing, Party Secretary and Executive Vice Chairman of the Association for Science and Technology in Pudong New District, Chen Jun, Director of the Innovation Services (Society Academic) Department, and other leaders came to Yuanwu Medical to carry out research and guidance work.

A series of guidance and suggestions were given on the development stage of the enterprise, and a "tailor-made" comprehensive plan for scientific and technological development was created for the enterprise.

2

Excellence Award in the finals of the 13th China Innovation and Entrepreneurship Competition, Disruptive Technology Innovation Competition

Sponsored by the Torch High-Tech Industrial Development Center of the Ministry of Industry and Information Technology.

The aim is to cultivate leading global companies, reshape the industrial competition landscape, and lay a solid foundation for future industrial development.

3

2024 Pharmaceutical Innovation Qipu Seeds Top 10

It is known as the "Oscar Award for the Medical and Health Industry".

Encourage the innovative vitality of early entrepreneurial innovators, help "seeds" break ground and achieve commercialization as soon as possible.

4

China Biotechnology Development Center collects innovative results

The "Osteoarthritis" project is included in the Innovation Achievements Manual of the 2024 China Biotechnology Innovation Conference.

The project team was invited by the organizer, China Biotechnology Development Center, to conduct a road show of innovative scientific and technological achievements.

5

Strategic cooperation was reached with Shanghai City Sixth People's Hospital

Explore new areas of iPSC technology application in the treatment of metabolic system diseases, and promote the introduction of safe, effective, and accessible quality stem cell drugs into clinical practice.

This is also the first time in the world that iPSC technology has been used to treat such diseases.

6

Reach strategic cooperation with Dongfulong Group

Focusing on the entire life cycle of iPS cell GMP production, the entire chain from cell collection and reception, testing, culture preparation, quality control, storage to treatment.

Jointly explore the world's leading full-scenario solution for the industrialization of iPSC technology.

Dongfeng is ready to open a new chapter with its accumulated power

The middle stream hits the water, and those who rush forward. 2024 is a year for the company to move forward steadily. This year, we shoulder our dreams and responsibilities, irrigate our harvests with sweat, and move forward with determination with hard work. Every arrival means a new departure, struggle, arrival, and starting again. The pace of time will never stop. In the constant of time, only those who forge ahead can strive for "variables".

In the new year, we will continue to maintain the spirit of "hard work", the energy of "pioneering", and the energy of "practical", welcome this new starting point with a more inclusive attitude, and jointly write a glorious chapter that belongs to us!

We live in a world full of innovation

But the times are rushing

We need stronger beliefs

precipitation energy storage

Turn invisible into tangible form

Create infinity in the finite

Scenery wins over the past and updates the year

Youth has no limits and innovation does not stop

our lives

Is to be reborn with a constant attitude of starting out

Be strong on the road to sustainable development

The "wild" journey has made extraordinary achievements

goodbye 

Dear 2024

May each of us be able to gather the past and welcome the stars

New Year's resolutions for 2025

Work hard and work hard to promote the scale industrialization of iPS cell drugs;

Be realistic and pragmatic, and strive to promote the clinical application of iPS cell drugs;

Pioneering and innovating, and striving to explore new paths for iPS cell drugs to treat diseases.